Hershey Trust Company’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Hershey Trust Company’s Portfolio EGRX Stock Details EGRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-2,138	Closed	-$92K	–	42
2021 Q2	$92K	Hold	2,138	–	–	﹤0.01%	32
2021 Q1	$89K	Hold	2,138	–	–	﹤0.01%	30
2020 Q4	$100K	Sell	2,138 -1,000	-32%	-$46.8K	﹤0.01%	27
2020 Q3	$133K	Hold	3,138	–	–	﹤0.01%	18
2020 Q2	$151K	Sell	3,138 -11,959	-79%	-$597K	﹤0.01%	12
2020 Q1	$694K	Hold	15,097	–	–	0.01%	12
2019 Q4	$907K	Hold	15,097	–	–	0.01%	7
2019 Q3	$854K	Hold	15,097	–	–	0.01%	8
2019 Q2	$841K	Hold	15,097	–	–	0.01%	9
2019 Q1	$762K	Hold	15,097	–	–	0.01%	8
2018 Q4	$608K	Hold	15,097	–	–	0.01%	8
2018 Q3	$1.05M	Hold	15,097	–	–	0.01%	3
2018 Q2	$1.14M	Hold	15,097	–	–	0.02%	4
2018 Q1	$795K	Hold	15,097	–	–	0.01%	4
2017 Q4	$806K	Hold	15,097	–	–	0.01%	5
2017 Q3	$900K	Hold	15,097	–	–	0.01%	6
2017 Q2	$1.19M	Buy	+15,097	New	+$1.23M	0.02%	5

Other funds holding EGRX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

SGCIA

Smith Graham & Co Investment Advisors Houston, Texas $868M AUM 24.69% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Hershey Trust Company's EGRX Position: Q3 2021 in Review

Hershey Trust Company sold out of Eagle Pharmaceuticals, Inc. (EGRX) in Q3 2021, closing a stake of 2,138 shares — an estimated $92K sold.

Hershey Trust Company first reported a position in EGRX in Q2 2017 and held it in 17 quarters. The position peaked at $1.19M in Q2 2017. 151 funds tracked by Wall St. Rank hold EGRX as of Q3 2021.

Hershey Trust Company reported no remaining Eagle Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
Hershey Trust Company sold 2,138 Eagle Pharmaceuticals, Inc. shares in Q3 2021, an estimated $92K.
Hershey Trust Company first reported a position in Eagle Pharmaceuticals, Inc. in Q2 2017 and held it in 17 quarters.
Hershey Trust Company's Eagle Pharmaceuticals, Inc. position peaked at $1.19M in Q2 2017.
151 funds tracked by Wall St. Rank held Eagle Pharmaceuticals, Inc. as of Q3 2021.

Based on Hershey Trust Company's 13F filing for Q3 2021, filed 12 Nov 2021.